What’s New in Ontosight® Terminal 1.1 A Complete Guide toRead More
OUR PIPELINE
With our partners in Biotech and Pharma we have built a track record of 32+ successful drug discovery and development partnerships at multiple stages of maturity, clinical development and market readiness. Together with our partners we drive therapeutics programs through all relevant inflection points independent of disease area and therapeutic modality.
- All (30)
- Oncology (06)
- Immunology & Inflammatory (04)
- Neurology (08)
- Cardio-Metabolic (02)
- Dermatology (03)
- Infectious, Pain & ICU (04)
- Rare diseases (03)
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Oncology | Solid tumors | AKAP-4 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Verik bio |
Oncology | Pancreatic cancer | PI3K | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Oncology | Multiple oncology indications | MetAP2 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Multiple oncology indications | OX40 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Pancreatic cancer | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Oncology and Inflammatory diseases | Confidential | PIM family | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Inflection Biosciences |
Immunology | Multiple immunology indications | IL-17 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio alpha |
Mental health disorders | Depression | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Anxiety | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Sleep disorder | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | ADHD | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Opoid abuse | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Schizophrenia | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Sensori-neural diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Metabolic diseases | T1D and co-morbidities | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Cardiology | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology + others | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Dermatology | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Infectious diseases | Antimicrobial resistance | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio beta |
Infectious diseases | Covid-19 | 3CLPro | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Pain related indications | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
ICU treatment | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Rare diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Rare diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Multiple TAs | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Oncology | Solid tumors | AKAP-4 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Verik bio |
Oncology | Pancreatic cancer | PI3K | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Oncology | Multiple oncology indications | MetAP2 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Multiple oncology indications | OX40 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Pancreatic cancer | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Oncology and Inflammatory diseases | Confidential | PIM family | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Inflection Biosciences |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Immunology | Multiple immunology indications | IL-17 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio alpha |
Mental health disorders | Depression | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Anxiety | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Sleep disorder | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | ADHD | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Opoid abuse | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Schizophrenia | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Sensori-neural diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Metabolic diseases | T1D and co-morbidities | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Cardiology | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Dermatology + others | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Dermatology | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Infectious diseases | Antimicrobial resistance | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio beta |
Infectious diseases | Covid-19 | 3CLPro | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Pain related indications | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
ICU treatment | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Rare diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Rare diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Multiple TAs | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Oncology | Solid tumors | AKAP-4 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Verik bio |
Oncology | Pancreatic cancer | PI3K | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Oncology | Multiple oncology indications | MetAP2 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Multiple oncology indications | OX40 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Pancreatic cancer | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Oncology and Inflammatory diseases | Confidential | PIM family | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Inflection Biosciences |
Immunology | Multiple immunology indications | IL-17 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio alpha |
Mental health disorders | Depression | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Anxiety | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Sleep disorder | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | ADHD | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Opoid abuse | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Schizophrenia | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Sensori-neural diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Metabolic diseases | T1D and co-morbidities | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Cardiology | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology + others | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Dermatology | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Infectious diseases | Antimicrobial resistance | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio beta |
Infectious diseases | Covid-19 | 3CLPro | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Pain related indications | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
ICU treatment | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Rare diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Rare diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Multiple TAs | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Oncology | Solid tumors | AKAP-4 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Verik bio |
Oncology | Pancreatic cancer | PI3K | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Oncology | Multiple oncology indications | MetAP2 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Multiple oncology indications | OX40 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Pancreatic cancer | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Oncology and Inflammatory diseases | Confidential | PIM family | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Inflection Biosciences |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Immunology | Multiple immunology indications | IL-17 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio alpha |
Mental health disorders | Depression | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Anxiety | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Sleep disorder | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | ADHD | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Opoid abuse | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Schizophrenia | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Sensori-neural diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Metabolic diseases | T1D and co-morbidities | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Cardiology | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Dermatology + others | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Dermatology | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Infectious diseases | Antimicrobial resistance | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio beta |
Infectious diseases | Covid-19 | 3CLPro | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Pain related indications | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
ICU treatment | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Rare diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Rare diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Multiple TAs | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |